Skip to main content
. 2016 Jan 26;4:e1619. doi: 10.7717/peerj.1619

Table 4. Arterial and coronary sinus blood gas analyses.

Results are presented as medians and ranges.

Control Isoflurane
T15 T30 Control T15 vs T30 T15 T30 Isoflurane T15 vs T30
Hbart (g/dl) 9.1 (7.5–10.0) 9.0 (7.8–10.9) 0.51 9.2 (8.1–10.3) 9.2 (7.6–11.6) 0.91
SaO2 (%) 99 (94.1–99.6) 99 (93.7–99.9) 1.0 99 (98.7–99.7) 99 (97.2–99.7) 0.31
PaO2 (mmHg) 163 (71–298) 153 (75–364) 0.43 200 (124–293) 213 (141–277) 0.28
PaCO2 (mmHg) 46 (38–54) 48 (39.7–51.7) 0.08 43 (35–55) 44 (34–50) 0.82
pHart 7.35 (7.24–7.41) 7.35 (7.22–7.38) 0.08 7.35 (7.24–7.44) 7.34 (7.28–7.45) 1.0
BEart (mmol/l) −0.4 (−7.6–1.3) −1.2 (−7.2–1.1) 0.55 −1.4 (−4.4–1.2) −2.4 (−3.6–0.1) 0.31
SBICart (mmol/l) 24.1 (18.2–25.5) 23.5 (18.5–25.5) 0.58 22.7 (20.7–24.2) 22.4 (21.4–24.6) 0.43
ScsO2 (%) 49 (23.5–82.9) 46 (39.3–74.9) 0.49 46 (29.7–74.5) 56 (33.1–80.3) 0.05
PcsO2 (mmHg) 26 (19–51) 27 (24–43) 0.70 27 (19–44) 33 (22–49) 0.006
PcsCO2 (mmHg) 56 (38–64) 58 (48–62) 0.06 54 (38–66) 55 (40–64) 1.0
pHcs 7.30 (7.14–7.35) 7.30 (7.17–7.32) 0.13 7.30 (7.19–7.42) 7.28 (7.23–7.40) 0.30
BEcs (mmol/l) 0.3 (−7.9–2.0) −0.1 (−6.8–1.9) 0.91 −1.4 (−3.9–0.7) −2.2 (−3.4–0.2) 0.02
SBICcs (mmol/l) 23.9 (17.0–25.3) 23.7 (18.1–25.2) 0.84 22.6 (20.8–24.3) 21.9 (21.3–24.2) 0.03
Lactatecs (mmol/l) 1.0 (0.6–5.8) 1.0 (0.5–5.3) 0.16 1.8 (1.0–3.0) 2.0 (0.8–2.7) 0.39
Isofluranecs (µg/dl) 0 0 0 1.4 (0.8–2.3)